Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lisata Therapeutics Inc LSTA

Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. Its lead investigational product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to penetrate solid tumors. LSTA1 actuates this active transport system in a tumor-specific manner, resulting in systemically co-administered anti-cancer drugs penetrating and accumulating in the tumor, while normal tissues are not affected. LSTA1 also has the potential to modify the tumor microenvironment (TME). It is exploring the potential of LSTA1 to enable a variety of treatment modalities to treat a range of solid tumors. Its CD34+ is a cell therapy technology was targeting an array of diseases, among them, critical limb ischemia, coronary microvascular dysfunction, and diabetic kidney disease.


NDAQ:LSTA - Post by User

Post by HugeMoneyon Sep 14, 2020 12:36pm
107 Views
Post# 31553165

Virtual Conference news- CLBS

Virtual Conference news- CLBS

Virtual Conference for Life Sciences Companies Broadcast Live September 17th, 2020

C.SIXWT.NRISLRXCLBS 

Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com

NEW YORK, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and industry professionals from around the world. This day-long virtual event will showcase live company presentations and interactive discussions focused on the life sciences industry.

Individual investors, institutional investors, advisors and analysts are invited to attend. The program opens at 9:15 AM ET on Thursday, September 17th with the first live webcast at 9:30 AM ET.

REGISTER NOW AT: https://bit.ly/3m5MTfY

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend the live presentations or ask questions.

Agenda and presenting companies:

Eastern
Time (ET)
Company Name Ticker(s)
9:30 AM Starpharma Holdings Ltd. OTCQX: SPHRY | ASX: SPL
10:00 AM VolitionRx Limited NYSE AMERICAN: VNRX
10:30 AM KemPharm, Inc. OTCQB: KMPH
11:00 AM Assure Holdings Corp. OTCQB: ARHH | TSX-V: IOM
11:30 AM aTyr Pharma, Inc. Nasdaq: LIFE
12:00 PM SWK Holdings, Inc Nasdaq: SWKH
12:30 PM Cardiol Therapeutics Inc. OTCQX: CRTPF | TSX: CRDL
1:00 PM XPhyto Therapeutics Corp. OTCQB: XPHYF | CSE: XPHY | FSE: 4XT
1:30 PM Nuvo Pharmaceuticals Inc. OTCQX: NRIFF | TSX: NRI
2:00 PM Salarius Pharmaceuticals, Inc. Nasdaq: SLRX
2:30 PM Willow Biosciences Inc. OTCQB: CANSF | TSX: WLLW
3:00 PM Orexo AB OTCQX: ORXOY | Nasdaq STO: ORX
3:30 PM Caladrius Biosciences, Inc. Nasdaq: CLBS
4:00 PM Kineta, Inc Private Company
4:30 PM Sixth Wave Innovations Inc. OTCQB: ATURF | CSE: SIXW | FSE: AHUH

To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com.

About Life Sciences Investor Forum
Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.

A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.


<< Previous
Bullboard Posts
Next >>